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dense subchondral bone may render cartilage more susceptible 
to compressive injury. Biomarkers of bone turnover are normal 
in the obese, but increase with even minor weight loss. Dyslipi- 
demia and hyperuricemia ssociated with obesity do not impact 
OA, but adipocyte synthesized hormones (leptin, adiponectin and 
resistin), cytokines (IL-1, 11-6 and TNF-~) and C-reactive protein 
warrant further research. BMI is a risk factor for progression of 
joint space narrowing, but the impact of obesity on progression 
of medial compartment kOA (mckOA) is largely explained by the 
presence of mild to moderate varus malalignment. Gait biome- 
chanics are impacted by pain, kOA and BMI. Maximum joint re- 
action forces (JRF) are 3-5 times body weight. Knee adduction 
moment (KAM),the largest contributor to the knee JRF, moves the 
knee in a varus direction throughout most of stance phase. Base- 
line high KAMs are associated with rapid progression of mckOA. 
Biomechanical studies in painful kOA have demonstrated e- 
creased knee range of motion in swing and stance phase, de- 
creased velocity, and stride length and increased KAM. Lower 
walking rates and stride lengths reduce the KAM, perhaps de- 
creasing pain in kOA. 
Eliminating knee pain normalizes the velocity and stride length 
and improves range of motion. Ankle and hip ROM and JRFs 
impact on knee JRFs but are less well studied. Obese subjects 
without knee pain also have slower velocity, shortened stride, 
widened stance, prolonged stance phase and larger ground reac- 
tion forces. The obese gait is more erect, with less hip flexion and 
less knee ROM. Ankle plantar flexion (ROM and forces at push- 
off) vary with the presence of knee pain. This may be an effort 
to redistribute knee JRFs or inability to generate sufficient forces 
during the gait cycle because of excess weight. In our studies, 
obese subjects who lost 100 pounds over 12-18 months following 
gastric bypass surgery experienced improvements in pain, func- 
tion and knee ROM during stance and swing phase, but the KAM 
and other kinetic parameters, which had been abnormal relative 
to normal weight controls, did not improve with weight loss. 
Understanding the effect of obesity on kOA will help with both 
symptomatic patient management and disease modification. 
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ADIPOKINES AND OSTEOARTHRITIS 
P Pottie 
OA is considered as a disease of the whole joint that may re- 
sult from multiple pathological mechanisms, one of which may be 
the dysregulation of lipid homeostasis. Adipokines are hormones 
synthesized by adipocytes that signal changes in the mass of adi- 
pose tissue and energy status to other organs that control fuel us- 
age. Many arguments showed that adipokines are implicated in 
the mechanism of degenerative breakdown of cartilage and also 
osteophytes formation; leptin and its receptors have been identi- 
fied in human cartilage and display stimulatory effects on proteo- 
glycan synthesis in rats; location and the extent of leptin expres- 
sion were related to the degree of cartilage damage and paral- 
leled the expression of the growth factors IGF 1 -and TGF-I~; intra- 
articular injection of leptin into rat knee joints induced the synthe- 
sis of IGF1 and TGF-I~ in cartilage at both the messenger RNA 
and protein levels, and strongly stimulated the anabolic function 
of chondrocytes. Leptin levels in synovial fluid of patients with OA 
are higher than serum levels and are correlated with BMI. There 
is a gender disparity toward patients (leptin level in female > lep- 
tin levels in male) suggesting that leptin could explain the higher 
prevalence of OA in women. Furthermore, other adipokines uch 
as adiponectin and resistin were also found in synovial fluid of 
patients with OA at lower levels compared to serum. 
So OA seems to involve adipose factors such as leptin, resistin 
and adiponectin which may influence cartilage metabolism. Fur- 
ther works are required to determine the influence of adipokines 
on articular tissues and, if its presence in arthritic joint is cause 
or effect of OA. 
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GROWTH FACTOR NETWORKS IN OSTEOARTHRITIS 
Anneliese D Recklies 
The development and maintenance of articular cartilage and its 
repair following traumatic or degenerative injury are often thought 
of mechanistically as similar processes, with establishment of a 
functional matrix as the final objective. In addition to the well- 
studied IGF-1 and TGF-I~ growth factor families new families of 
growth factors which may regulate cartilage homeostasis have 
been described more recently, amongst them the connective tis- 
sue growth factor family and members of the chitinase 3-like pro- 
tein family. The chitinase 3-like proteins are unique in that they 
apparently do not play a major role in growth and development 
of articular cartilage, but are abundantly expressed in injured or 
degenerate tissue. The mechanisms by which they affect connec- 
tive tissue turnover will be reviewed. In addition these proteins are 
expressed in many organs during the processes leading to tissue 
fibrosis, which involves the excessive growth of connective tis- 
sue cells and deposition of extracellular matrix. Both TGF-I~ and 
connective tissue growth factors have been implicated in these 
processes. Adult articular chondrocytes, particularly in the super- 
ficial region, display a number of features and response pattern 
suggestive of a fibrotic response. The case will be made that fi- 
brotic reactions could be part of the response repertoire of adult 
articular chondrocytes to tissue injury. 
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GENE THERAPY APPROACHES TO CARTILAGE REPAIR 
CH Evans 
Gene transfer promises to enhance the reparative activities of 
cells involved in the healing of focal cartilage lesions. Among the 
advantages of this approach is the unique ability to express spe- 
cific gene products locally within the defect for an extended period 
of time. Traditional gene therapy strategies include the ex viva ex- 
pansion and genetic modification of autologous chondrocytes or 
chondroprogenitor cells that are subsequently seeded onto scaf- 
folds and implanted into the lesion. Although biologically promis- 
ing, such technologies are unlikely to be cost-effective and con- 
venient in clinical practice. As an alternative, we are developing 
expedited approaches that do not require multiple ex viva cultur- 
ing steps or artificial scaffolds, and can be accomplished in a sin- 
gle operative procedure. To this end, autologous bone marrow is 
being investigated as a convenient source of chondroprogenitor 
cells that can be genetically modified and, following coagulation, 
press-fit into cartilage lesions during a single procedure. 
We have found that bone marrow aspirates obtained from the il- 
iac crests of rabbits can be reproducibly clotted following genetic 
modification with adenoviral vectors and mediate transgene ex- 
pression for at least 2 weeks when cultured in situ. Moreover, 
after the transfer of suitable chondrogenic DNAs, bone marrow 
clots undergo chondrogenesis in culture without he need for en- 
dogenous chondrogenic factors. Based upon these observations, 
we have developed an intra-operative surgical procedure in which 
marrow is retrieved from the rabbit and combined with suspen- 
sions of recombinant adenovirus while coagulation occurs. The 
genetically modified coagulum ("gene plug") is then press-fit into 
the cartilage lesion where transgene expression persists. Pre- 
liminary data suggest that chondrogenesis occurs within the im- 
planted material, leading to the formation of cartilaginous repair 
tissue. Once optimized, this type of procedure promises to pro- 
